257892-43-6 Usage
General Description
(3-HYDROXY-3-PHENYL-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER, also known as N-tert-butyl (3-hydroxy-3-phenylpropyl)carbamate, is a chemical compound used in the synthesis of pharmaceuticals and organic compounds. It is typically used as a reagent in organic chemistry reactions and as an intermediate in the production of various pharmaceuticals. (3-HYDROXY-3-PHENYL-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER is a white solid with a molecular formula of C14H21NO3 and a molecular weight of 251.32 g/mol. As a tert-butyl ester, it exhibits high stability and can be easily handled and stored. Additionally, it has potential applications in the development of new drug candidates and in medicinal chemistry research.
Check Digit Verification of cas no
The CAS Registry Mumber 257892-43-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,7,8,9 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 257892-43:
(8*2)+(7*5)+(6*7)+(5*8)+(4*9)+(3*2)+(2*4)+(1*3)=186
186 % 10 = 6
So 257892-43-6 is a valid CAS Registry Number.
InChI:InChI=1/C14H21NO3/c1-14(2,3)18-13(17)15-10-9-12(16)11-7-5-4-6-8-11/h4-8,12,16H,9-10H2,1-3H3,(H,15,17)
257892-43-6Relevant articles and documents
HYDROXY ALIPHATIC SUBSTITUTED PHENYL AMINOALKYL ETHER DERIVATIVES
-
Paragraph 0292-0293; 0365-0366, (2015/12/24)
New hydroxy aliphatic substituted phenyl aminoalkyl ether compounds of formula (I), compositions thereof and their use as a medicament in the treatment of nervous system diseases and/or the treatment of developmental, behavioral and/or mental disorders associated with cognitive deficits.
CARBOXYLIC ACID ARYL AMIDES
-
Page/Page column 12; 13, (2012/07/28)
Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer.
PYRIDO PYRIMIDINES
-
, (2012/07/28)
Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.
